Factors Associated With Antipsychotic Polypharmacy and High-Dose Antipsychotics Among Individuals Receiving Compulsory Treatment in the Community

被引:10
|
作者
Gisev, Natasa [1 ]
Bell, J. Simon [2 ,3 ,4 ]
Chen, Timothy F. [1 ]
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Monash Univ, Ctr Med Use & Safety, Fac Pharm & Pharmaceut Sci, Parkville, Vic, Australia
[3] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland
[4] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
关键词
antipsychotic agents; commitment of mentally ill; community mental health services; drug utilization; logistic models; LONG-ACTING INJECTIONS; TREATMENT ORDERS; SCHIZOPHRENIA; CLOZAPINE; DRUGS; AUGMENTATION; TOLERABILITY; PREVALENCE; KNOWLEDGE; ATTITUDES;
D O I
10.1097/JCP.0000000000000098
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Community treatment orders (CTOs) are a form of compulsory treatment of individuals with a mental illness in the community. The objectives of this study were to determine the demographic, clinical, and treatment plan factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals issued with a CTO. This was a secondary analysis of all 377 individuals who were prescribed an antipsychotic, extracted from a retrospective study of 378 individuals issued with a CTO by the New South Wales Mental Health Review Tribunal in Australia in 2009. Deidentified information relating to individuals' treatment plans, demographic, and clinical details were systematically extracted. Of the 377 individuals, 121 (32%) were prescribed antipsychotic polypharmacy and 101 (27%) high-dose antipsychotics. Unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) for factors associated with antipsychotic polypharmacy and high-dose antipsychotics were computed using binary logistic regression. There was a strong association between the use of antipsychotic polypharmacy and high-dose antipsychotics (P < 0.001). Only treatment plan factors were associated with antipsychotic polypharmacy and high-dose antipsychotics in adjusted models. Although first-generation long-acting injectable antipsychotics and clozapine were associated with antipsychotic polypharmacy (adjusted OR, 9.12; 95% CI, 4.21-19.74; adjusted OR, 7.97; 95% CI, 2.93-21.72), oral second-generation antipsychotics and risperidone long-acting injection were associated with high-dose antipsychotics (adjusted OR, 5.67; 95% CI, 2.89-11.12; adjusted OR, 8.14; 95% CI, 3.22-20.53). Therefore, the use of antipsychotic polypharmacy and high-dose antipsychotics among individuals issued with CTOs is associated only with the drugs prescribed in their treatment plans and not their individual demographic and clinical characteristics.
引用
下载
收藏
页码:307 / 312
页数:6
相关论文
共 50 条
  • [21] Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US Adults
    Marcela Horvitz-Lennon
    Rita Volya
    Katya Zelevinsky
    Mimi Shen
    Julie M. Donohue
    Andrew Mulcahy
    Sharon-Lise T. Normand
    Administration and Policy in Mental Health and Mental Health Services Research, 2022, 49 : 59 - 70
  • [22] Cone damage in patients receiving high-dose irofulven treatment
    Lee, MS
    Gupta, N
    Penson, RT
    Loewenstein, J
    Wepner, MS
    Seiden, MV
    Milam, AH
    ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (01) : 29 - 34
  • [23] The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder
    Gianfrancesco, Frank D.
    Sajatovic, Martha
    Rajagopalan, Krithika
    Wang, Ruey-Hua
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 305 - 316
  • [24] Obesity and associated outcomes among nulliparas receiving high-dose versus standard-dose oxytocin for labor augmentation
    Stetson, Bethany T.
    Roy, Archana
    Song, Jing
    Miller, Emily S.
    Peaceman, Alan M.
    Son, Moeun
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S661 - S661
  • [25] Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
    Takahashi, Tatsuichiro
    Otsubo, Tetsuya
    Kunisawa, Susumu
    Noriko, Sasaki
    Imanaka, Yuichi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (03) : 224 - 231
  • [26] High-dose opioid utilization and mortality among individuals initiating hemodialysis
    Matthew Daubresse
    G. Caleb Alexander
    Deidra C. Crews
    Dorry L. Segev
    Krista L. Lentine
    Mara A. McAdams-DeMarco
    BMC Nephrology, 22
  • [27] Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors
    Stein, Bradley D.
    Sherry, Tisamarie B.
    O'Neill, Brenna
    Taylor, Erin A.
    Sorbero, Mark
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (07) : 1603 - 1609
  • [28] Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors
    Bradley D. Stein
    Tisamarie B. Sherry
    Brenna O’Neill
    Erin A. Taylor
    Mark Sorbero
    Journal of General Internal Medicine, 2022, 37 : 1603 - 1609
  • [29] Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment
    Vivas-Valencia, Carolina
    Dong, Huiru
    Stringfellow, Erin J.
    Russell, W. Alton
    Morgan, Jake R.
    Tadrous, Mina
    Jalali, Mohammad S.
    JAMA NETWORK OPEN, 2023, 6 (11) : E2341416
  • [30] AVASCULAR NECROSIS OF BONE IN CHILDREN RECEIVING HIGH-DOSE STEROID TREATMENT
    GREGG, PJ
    BARSOUM, MK
    SOPPITT, D
    JACKSON, RH
    BRITISH MEDICAL JOURNAL, 1980, 281 (6233): : 116 - 116